Organogenesis Holdings
ORGO
20 hedge funds and large institutions have $6.17M invested in Organogenesis Holdings in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0.89% more ownership
Funds ownership: 0% → 0.89% (+0.89%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.84M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.67M |
| 3 |
Goldman Sachs
New York
|
+$2.03M |
| 4 |
BlackRock
New York
|
+$1.36M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$1.26M |
Top Sellers
ORGO Hedge Fund Activity: Q1 2019 in Review
20 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2019, worth a combined $6.17M.
Buyers outnumbered sellers: 20 funds opened new ORGO positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $4.84M.
- 20 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $6.17M of Organogenesis Holdings stock for Q1 2019.
- 20 funds opened new Organogenesis Holdings positions in Q1 2019 and 0 closed out, a net change of +20 holders.
- The largest Organogenesis Holdings buyer in Q1 2019 was Vanguard Group, an estimated $4.84M added.
Based on aggregated 13F filings for Q1 2019.